Position in VREX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,887,882
-$1,765,689 QoQ
Shares Held
468,637
-25.3% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 186 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VREX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $3,192,742,950 across 81 Medical Devices names. VREX ranks #32 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
9,681,750 | $413,217,085 | |
| 2 | ABT |
Abbott Laboratories
|
4,193,058 | $380,478,079 | |
| 3 | PODD |
Insulet Corp
|
2,455,135 | $373,794,300 | |
| 4 | STE |
STERIS plc
|
1,377,297 | $290,017,425 | |
| 5 | MDT |
Medtronic plc
|
3,299,627 | $258,129,817 | |
| 6 | DXCM |
Dexcom Inc
|
3,237,720 | $218,060,438 | |
| 7 | LIVN |
LivaNova PLC
|
2,356,191 | $193,749,582 | |
| 8 | HAE |
Haemonetics Corp
|
2,266,489 | $169,986,675 |
All Filings in VREX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,887,882 | 468,637 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $6,653,571 | 627,104 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,657,786 | 571,484 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,019,195 | 404,774 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,088,970 | 471,623 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $3,639,544 | 313,754 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $8,329,079 | 570,876 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $5,766,633 | 483,778 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $4,095,926 | 278,067 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $5,358,992 | 296,077 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $5,061,900 | 246,922 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,522,320 | 240,677 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,978,564 | 126,371 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,593,057 | 142,554 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,432,061 | 119,806 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,977,562 | 93,546 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,406,478 | 65,754 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,142,080 | 53,644 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $864,627 | 27,405 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $688,342 | 54,115 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,102,071 | 72,744 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $526,826 | 23,198 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||